Melena D Bellin1, Gregory J Beilman2, David Er Sutherland3, Hawa Ali2, Arzu Petersen2, Steven Mongin4, Varvara Kirchner2, Sarah J Schwarzenberg5, Guru Trikudanathan6, Martin L Freeman6, Timothy L Pruett2, Srinath Chinnakotla7. 1. Department of Surgery, University of Minnesota Medical School, Minneapolis, MN; Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN. 2. Department of Surgery, University of Minnesota Medical School, Minneapolis, MN. 3. Department of Surgery, University of Minnesota Medical School, Minneapolis, MN; Schulze Diabetes Institute, University of Minnesota Medical School, Minneapolis, MN. 4. Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, University of Minnesota Medical School, Minneapolis, MN. 5. Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN. 6. Department of Medicine, University of Minnesota Medical School, Minneapolis, MN. 7. Department of Surgery, University of Minnesota Medical School, Minneapolis, MN; Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN. Electronic address: chinni@umn.edu.
Abstract
BACKGROUND: A total pancreatectomy and intraportal islet cell autotransplant (TPIAT) is increasingly being offered to patients with chronic pancreatitis (CP). The benefits include removal of the root cause of pain and amelioration of diabetes. However, the long-term durability of this operation remains unclear. STUDY DESIGN: Of the 742 patients who have undergone a TPIAT at our center, 215 who did so between 1998 and 2008 now have at least 10 years of follow-up time and were eligible for this single-center observational study. Our outcomes measures included abdominal pain relief, narcotic use, islet graft function (subdivided into 3 groups: insulin independence; partial graft function, defined by C-peptide level > 0.6 mg/dL; and no function, defined by C-peptide level < 0.6 mg/dL), and health-related quality of life. RESULTS: The 10-year actuarial survival rate was 72%. A BMI > 30 kg/m2 (p = 0.04) predicted 10-year mortality. The rates of pain relief were 82% at 10 years and 90% at 15 years. Narcotic use declined with time: the rates were 50% at 5 years and 37% at 10 years. At 10 years, the rate of insulin independence was 20%; the rate of partial graft function, 32%. Transplantation of islet equivalents/kg > 4,000 was the strongest predictor of islet graft function at 10 years. Pediatric patients were more likely to have islet function than adults (p = 0.01). Health-related quality of life continued to improve at 10 years, even in patients on narcotics. CONCLUSIONS: This represents the first and largest series to examine long-term outcomes (10 years or more) in TPIAT patients. In our series, this dual procedure produced durable pain relief and sustained islet graft function, even past 10 years postoperatively.
BACKGROUND: A total pancreatectomy and intraportal islet cell autotransplant (TPIAT) is increasingly being offered to patients with chronic pancreatitis (CP). The benefits include removal of the root cause of pain and amelioration of diabetes. However, the long-term durability of this operation remains unclear. STUDY DESIGN: Of the 742 patients who have undergone a TPIAT at our center, 215 who did so between 1998 and 2008 now have at least 10 years of follow-up time and were eligible for this single-center observational study. Our outcomes measures included abdominal pain relief, narcotic use, islet graft function (subdivided into 3 groups: insulin independence; partial graft function, defined by C-peptide level > 0.6 mg/dL; and no function, defined by C-peptide level < 0.6 mg/dL), and health-related quality of life. RESULTS: The 10-year actuarial survival rate was 72%. A BMI > 30 kg/m2 (p = 0.04) predicted 10-year mortality. The rates of pain relief were 82% at 10 years and 90% at 15 years. Narcotic use declined with time: the rates were 50% at 5 years and 37% at 10 years. At 10 years, the rate of insulin independence was 20%; the rate of partial graft function, 32%. Transplantation of islet equivalents/kg > 4,000 was the strongest predictor of islet graft function at 10 years. Pediatric patients were more likely to have islet function than adults (p = 0.01). Health-related quality of life continued to improve at 10 years, even in patients on narcotics. CONCLUSIONS: This represents the first and largest series to examine long-term outcomes (10 years or more) in TPIAT patients. In our series, this dual procedure produced durable pain relief and sustained islet graft function, even past 10 years postoperatively.
Authors: Stefan A W Bouwense; Marinus A Kempeneers; Hjalmar C van Santvoort; Marja A Boermeester; Harry van Goor; Marc G Besselink Journal: Visc Med Date: 2019-04-04
Authors: Chathura B B Ratnayake; Sivesh K Kamarajah; Benjamin P T Loveday; Manu Nayar; Kofi Oppong; Steve White; Jeremy J French; John A Windsor; Sanjay Pandanaboyana Journal: J Gastrointest Surg Date: 2020-07-23 Impact factor: 3.452
Authors: Emily R Perito; John F Pohl; Caitlin Bakker; Matthew A Armfield; Bradley Barth; Addison Cuneo; Maria Mascarenhas; Megha Mehta; Sarah Jane Schwarzenberg Journal: Pancreas Date: 2022-02-01 Impact factor: 3.327
Authors: Damian Grybowski; Piotr J Bachul; Jordan S Pyda; Mark Kijek; Natalie Fillman; Angelica Perez-Gutierrez; Lindsay Basto; Karolina Golab; Ling-Jia Wang; Martin Tibudan; Aaron Lucander; Ruba Azzam; Jędrzej Chrzanowski; Wojciech Fendler; John Fung; Jeffrey B Matthews; Sajan Nagpal; Piotr Witkowski; Mark B Slidell Journal: Pediatr Surg Int Date: 2021-07-10 Impact factor: 1.827
Authors: Guru Trikudanathan; B Joseph Elmunzer; Yi Yang; Maisam Abu-El-Haija; David Adams; Syed Ahmad; Appakalai N Balamurugan; Gregory J Beilman; Srinath Chinnakotla; Darwin L Conwell; Martin L Freeman; Timothy B Gardner; Betul Hatipoglu; James S Hodges; Varvara Kirchner; Luis F Lara; Leslie Long-Simpson; Rebecca Mitchell; Katherine Morgan; Jaimie D Nathan; Bashoo Naziruddin; Andrew Posselt; Timothy L Pruett; Sarah J Schwarzenberg; Vikesh K Singh; Kerrington Smith; Martin Wijkstrom; Piotr Witkowski; Melena D Bellin Journal: Pancreatology Date: 2020-11-24 Impact factor: 3.996
Authors: Kendall R McEachron; Yi Yang; James S Hodges; Gregory J Beilman; Varvara A Kirchner; Timothy L Pruett; Srinath Chinnakotla; Bernhard J Hering; Melena D Bellin Journal: Transpl Int Date: 2020-10-27 Impact factor: 3.782